Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
77,497,222
-
Share change
-
+3,720,616
-
Total reported value
-
$554,890,125
-
Put/Call ratio
-
161%
-
Price per share
-
$7.16
-
Number of holders
-
190
-
Value change
-
+$25,218,463
-
Number of buys
-
80
-
Number of sells
-
85
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q3 2021
As of 30 Sep 2021,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,497,222 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, D. E. Shaw & Co., Inc., WASATCH ADVISORS INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
190
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.